|

Armored Dendritic Cell Injection Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • Shanghai Cell Therapy Group Co.,Ltd1

Indications

  • Adjuvant Therapy1
  • Solid Cancers1
  • Cancer1

Other1 trial

An Antibody-armored Dendritic Cell in Patients With Solid Tumors
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.